Complications of Gastrointestinal Bleeding

The role of anticoagulant therapy in bleeding

Hemorrhagic complications remain the main and most dangerous side effect of any anticoagulant therapy. Internal bleeding, primarily gastrointestinal, as well as intracranial and urogenital, can occur at both therapeutic and toxic dosages.

• Indirect anticoagulants (e.g., warfarin): have a cumulative effect and a long half-life. The risk of overdose and subsequent GIB increases exponentially due to multiple interactions with other drugs (antibiotics, NSAIDs, antifungals).
• Heparins and direct thrombin inhibitors: can also cause severe hemorrhages. At the same time, the drug bivalirudin is associated with a lower bleeding rate compared to standard heparin.
• Errors in antidote administration: paradoxically, an excess of protamine sulfate (a specific heparin antidote) can itself provoke bleeding, as this substance actively interacts with fibrinogen and platelets.

Gastrointestinal bleeding in vascular diseases

Vascular wall damage (vasopathies and vasculitis) leads to a vasculitic-purpuric type of bleeding. The gastrointestinal tract often becomes a target in systemic inflammatory processes.

1. Hemorrhagic vasculitis (Henoch-Schönlein purpura): the abdominal syndrome manifests as acute abdominal pain and carries a high risk of gastrointestinal hemorrhage. This symptom may be the onset of the disease, preceding the appearance of characteristic symmetrical skin rashes and joint syndrome.
2. Rendu-Osler-Weber disease: a classic example of hereditary vasopathy. The pathology manifests as recurrent bleeding (nasal and gastrointestinal) from thinned, locally dilated mucosal vessels. An important diagnostic marker is that coagulation and platelet hemostasis parameters remain within normal limits.

Secondary vasopathies associated with the risk of GIB can develop against the background of severe infections (sepsis, infective endocarditis) and drug-induced vasculitis.

Platelet and coagulation hemostasis disorders

In the microcirculatory (petechial-macular) type of bleeding, characteristic of thrombopathies, GIB occurs alongside small ecchymoses and mucosal bleeding.

• Glanzmann thrombasthenia: a hereditary platelet receptor defect leading to recurrent GI hemorrhages, heavy menorrhagia, and immediate bleeding after trauma (with a normal platelet count).
• Werlhof's disease (ITP): gastrointestinal bleeding is less common; however, a critical drop in the platelet count below 10–20×10⁹/L provokes severe spontaneous hemorrhages.
• Hemoblastoses: bleeding is multifactorial in nature (thrombocytopenia, leukemic vascular infiltration, liver failure).

In DIC (consumption coagulopathy), spontaneous gastrointestinal bleeding is a prominent marker of the overt hemorrhagic phase. DIC can develop against the background of shock, sepsis, or massive blood transfusions (which are often required to treat the GIB itself). In the terminal stage of DIC, severe hemorrhagic syndrome is combined with diffuse microthrombosis, leading to irreversible multiple organ failure.

What else to study on this topic

• Pathogenesis and stages of DIC
• Differential diagnosis of hemorrhagic vasculitis
• Heparin-induced thrombocytopenia (HIT)
• Hereditary coagulopathies (hemophilia A and B, von Willebrand disease)
• Acquired coagulopathies in liver diseases

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.